JPMorgan lowered the firm’s price target on Doximity (DOCS) to $60 from $63 and keeps a Neutral rating on the shares. The firm updated the company’s model.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
- Doximity call volume above normal and directionally bullish
- Doximity price target lowered to $50 from $80 at Goldman Sachs
- Doximity price target lowered to $65 from $87 at Baird
- Doximity’s Stock Decline Offers a Compelling Buy Opportunity Amid Strong Performance and Growth Potential
- Doximity’s Earnings Call: Strong Growth Amid Caution
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue